(Q45866935)

17 December 2017

title

Cytokine gene therapy with interleukin-2-transduced fibroblasts: effects of IL-2 dose on anti-tumor immunity (English)

1 reference

17 December 2017

Cytokine Gene Therapy with Interleukin-2-Transduced Fibroblasts: Effects of IL-2 Dose on Anti-Tumor Immunity (English)

1 reference

https://api.crossref.org/works/10.1089/HUM.1995.6.5-591

20 May 2024

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7578396

20 May 2024

author name string

H. Fakhrai

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7578396

20 May 2024

D. L. Shawler

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7578396

20 May 2024

R. Gjerset

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7578396

20 May 2024

R. K. Naviaux

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7578396

20 May 2024

J. Koziol

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7578396

20 May 2024

I. Royston

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7578396

20 May 2024

R. E. Sobol

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7578396

20 May 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7578396

20 May 2024

publication date

1 May 1995

1 reference

17 December 2017

full work available at URL

http://www.liebertpub.com/doi/pdf/10.1089/hum.1995.6.5-591

1 reference

https://api.crossref.org/works/10.1089/HUM.1995.6.5-591

20 May 2024

1 reference

17 December 2017

volume

6

1 reference

17 December 2017

issue

5

1 reference

17 December 2017

page(s)

591-601

1 reference

17 December 2017

Human renal carcinoma line transfected with interleukin-2 and/or interferon alpha gene(s): implications for live cancer vaccines

cites work

1

1 reference

https://api.crossref.org/works/10.1089/HUM.1995.6.5-591

20 May 2024

2

40

2142

BRATTAIN M.G.

1980

1 reference

https://api.crossref.org/works/10.1089/HUM.1995.6.5-591

Local administration of cells containing an inserted IL-2 gene and producing IL-2 inhibits growth of human tumours in nu/nu mice

20 May 2024

3

1 reference

https://api.crossref.org/works/10.1089/HUM.1995.6.5-591

Cellular replacement therapy for neurologic disorders: potential of genetically engineered cells

20 May 2024

5

1 reference

https://api.crossref.org/works/10.1089/HUM.1995.6.5-591

20 May 2024

Analytical Biochemistry

6

162

156

SACCHI N.

1987

1 reference

https://api.crossref.org/works/10.1089/HUM.1995.6.5-591

20 May 2024

7

35

2434

CORBETT T.H.

1975

1 reference

https://api.crossref.org/works/10.1089/HUM.1995.6.5-591

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

20 May 2024

10

1 reference

https://api.crossref.org/works/10.1089/HUM.1995.6.5-591

Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response

20 May 2024

12

1 reference

https://api.crossref.org/works/10.1089/HUM.1995.6.5-591

20 May 2024

Hepato-Gastroenterology

14

36

352

GANDOLFI L.

1989

1 reference

https://api.crossref.org/works/10.1089/HUM.1995.6.5-591

Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity

20 May 2024

15

1 reference

https://api.crossref.org/works/10.1089/HUM.1995.6.5-591

Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4.

20 May 2024

16

1 reference

https://api.crossref.org/works/10.1089/HUM.1995.6.5-591

Interleukin 7 induces CD4+ T cell-dependent tumor rejection

20 May 2024

17

1 reference

https://api.crossref.org/works/10.1089/HUM.1995.6.5-591

Activation of gamma delta T cells in the primary immune response to Mycobacterium tuberculosis

20 May 2024

18

1 reference

https://api.crossref.org/works/10.1089/HUM.1995.6.5-591

In vivo evaluation of the effects of interleukins 2, 4 and 7 on enhancing the immunotherapeutic efficacy of anti-tumor cytotoxic T lymphocytes

20 May 2024

21

1 reference

https://api.crossref.org/works/10.1089/HUM.1995.6.5-591

Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production

20 May 2024

22

1 reference

https://api.crossref.org/works/10.1089/HUM.1995.6.5-591

20 May 2024

23

7

980

MILLER A.D.

1989

1 reference

https://api.crossref.org/works/10.1089/HUM.1995.6.5-591

Molecular cloning of the cDNA for tissue factor, the cellular receptor for the initiation of the coagulation protease cascade.

20 May 2024

24

1 reference

https://api.crossref.org/works/10.1089/HUM.1995.6.5-591

[21] Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction

20 May 2024

25

1 reference

https://api.crossref.org/works/10.1089/HUM.1995.6.5-591

NIH conference. New approaches to the immunotherapy of cancer using interleukin-2.

20 May 2024

27

1 reference

https://api.crossref.org/works/10.1089/HUM.1995.6.5-591

Inhibition of tumor growth by histoincompatible cells expressing interleukin-2

20 May 2024

28

1 reference

https://api.crossref.org/works/10.1089/HUM.1995.6.5-591

The IL-2/IL-2 receptor system: a current overview

20 May 2024

32

1 reference

https://api.crossref.org/works/10.1089/HUM.1995.6.5-591

20 May 2024

33

54

182

ZEH H.J.

1994

1 reference

https://api.crossref.org/works/10.1089/HUM.1995.6.5-591

Murine interleukin-4 displays potent anti-tumor activity in vivo

20 May 2024

34

1 reference

https://api.crossref.org/works/10.1089/HUM.1995.6.5-591

Induction of antitumor immunity by interleukin-2 gene-transduced mouse mammary tumor cells versus transduced mammary stromal fibroblasts

20 May 2024

35

1 reference

https://api.crossref.org/works/10.1089/HUM.1995.6.5-591

Exogenous expression of mouse interferon gamma cDNA in mouse neuroblastoma C1300 cells results in reduced tumorigenicity by augmented anti-tumor immunity

20 May 2024

36

1 reference

https://api.crossref.org/works/10.1089/HUM.1995.6.5-591

Isolation and characterization of a human interleukin cDNA clone, homologous to mouse B-cell stimulatory factor 1, that expresses B-cell- and T-cell-stimulating activities

20 May 2024

37

1 reference

https://api.crossref.org/works/10.1089/HUM.1995.6.5-591

20 May 2024

Identifiers

1 reference

17 December 2017

1 reference

17 December 2017